This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Invitrogen Corporation, Life Technologies Corporation. Active years: 2002-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2009
Title: The Innovations of William Biddle
Introduction
William Biddle is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of cell culture and media formulations. With a total of 4 patents, his work has advanced the understanding and application of cell growth and nutrient supplementation.
Latest Patents
Biddle's latest patents include innovations in dry powder cells and cell culture reagents. His methods and compositions involve nutritive media, media supplements, media subgroups, and buffer formulations. These formulations are designed to produce specific ionic and pH conditions when reconstituted with a solvent. Additionally, he has developed methods for producing sterile powdered media and growth factors, utilizing techniques such as gamma irradiation. His inventions also encompass methods for cultivating both procaryotic and eukaryotic cells, including human cells.
Career Highlights
Throughout his career, William Biddle has worked with prominent companies in the biotechnology sector, including Invitrogen Corporation and Life Technologies Corporation. His expertise in cell culture and media formulations has positioned him as a valuable asset in these organizations.
Collaborations
Biddle has collaborated with notable colleagues such as Richard M. Fike and Barbara M. Dadey. Their combined efforts have contributed to advancements in the field of cell culture and nutrient supplementation.
Conclusion
William Biddle's innovative work in cell culture and media formulations has led to significant advancements in the biotechnology industry. His contributions continue to impact the way cells are cultivated and supported in research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

